Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000669806 | SCV000794593 | likely pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2D | 2017-10-02 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000669806 | SCV003337272 | likely pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2D | 2023-08-21 | criteria provided, single submitter | clinical testing | This sequence change affects a splice site in intron 7 of the SGCA gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in SGCA are known to be pathogenic (PMID: 9192266). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with SGCA-related conditions. ClinVar contains an entry for this variant (Variation ID: 554218). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. |
Genome- |
RCV000669806 | SCV003931707 | likely pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2D | 2023-02-08 | criteria provided, single submitter | clinical testing |